deltatrials
Completed PHASE3 INTERVENTIONAL 4-arm NCT02992925

Phase 3 Study of BK1310 in Healthy Infants

Sponsor: Tanabe Pharma Corporation

Conditions Immunization; Infection
Interventions DPT-IPV DPT-IPV-Hib-High（Combined Vaccine） DPT-IPV-Hib-Low（Combined Vaccine） Hib vaccine
Updated 11 times since 2017 Last updated: Dec 15, 2025 Started: Nov 30, 2016 Primary completion: Dec 31, 2017 Completion: Nov 30, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02992925, this PHASE3 trial focuses on Immunization; Infection and remains completed. Sponsored by Tanabe Pharma Corporation, it has been updated 11 times since 2016, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Jan 2017 – ~Feb 2018 · 13 months · monthly snapshotRecruiting~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshotActive Not Recruiting~Mar 2019 – ~Jan 2021 · 22 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshotCompleted~Feb 2025 – ~Sep 2025 · 7 months · monthly snapshotCompleted~Sep 2025 – ~Jan 2026 · 4 months · monthly snapshotCompleted~Jan 2026 – ~Feb 2026 · 31 days · monthly snapshotCompleted~Feb 2026 – present · 6 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Feb 2026 — Present [monthly]

    Completed PHASE3

  2. Jan 2026 — Feb 2026 [monthly]

    Completed PHASE3

  3. Sep 2025 — Jan 2026 [monthly]

    Completed PHASE3

  4. Feb 2025 — Sep 2025 [monthly]

    Completed PHASE3

  5. Sep 2024 — Feb 2025 [monthly]

    Completed PHASE3

▶ Show 6 earlier versions

  1. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  2. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  3. Mar 2019 — Jan 2021 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

  4. Jun 2018 — Mar 2019 [monthly]

    Active Not Recruiting PHASE3

  5. Feb 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  6. Jan 2017 — Feb 2018 [monthly]

    Recruiting PHASE3

    First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Tanabe Pharma Corporation
  • The Research Foundation for Microbial Diseases of Osaka University
Data source: Tanabe Pharma Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations